Navigation Links
Watson Launches Generic Concerta®
Date:5/2/2011

PARSIPPANY, N.J., May 2, 2011 /PRNewswire/ -- Watson Pharmaceuticals, Inc. (NYSE: WPI) today confirmed that its subsidiary, Watson Laboratories, Inc., has launched an authorized generic version of Concerta® (methylphenidate hydrochloride extended-release tablets) as part of an exclusive agreement with Ortho-McNeil-Janssen Pharmaceuticals, Inc. (OMJPI).  Watson began shipping the product today.  Concerta is approved for the treatment of attention deficit hyperactivity disorder (ADHD) in children ages 6 to 17 and in adults 18 to 65, as part of a total treatment program that may include counseling or other therapies.

Under the terms of the exclusive supply and distribution agreement, OMJPI manufactures and supplies Watson with all dosage strengths of the authorized generic product. Watson markets and distributes the product in the United States. OMJPI will receive a share of the net sales from Watson's sales of the product. The agreement runs until the end of 2014. During the term of the agreement, Watson may continue to pursue U.S. Food and Drug Administration approval of its abbreviated new drug application (ANDA) for a generic version of Concerta and may launch its own ANDA product at the conclusion of the exclusive supply agreement. Other terms of the agreement have not been disclosed.

For the most recent twelve months ending February 28, 2011, Concerta had sales of approximately $1.5 billion, according to IMS Health data.

About Watson Pharmaceuticals, Inc.Watson Pharmaceuticals, Inc. is an integrated global specialty pharmaceutical company. The Company is engaged in the development, manufacturing, marketing and distribution of generic pharmaceuticals and specialized branded pharmaceutical products focused on Urology and Women's Health. Watson has operations in many of the world's established and growing international markets.

For pres
'/>"/>

SOURCE Watson Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Watson Pharmaceuticals to Webcast Annual Meeting of Stockholders on May 13th
2. Watson First Quarter 2011 Net Revenue Increases to $877 Million
3. New Life Agency Adds Watson to Join Walgreens on The Fertility Pharmacy Care Card for Fertility Medication
4. Watson Confirms Welchol® Patent Challenge
5. Columbia Laboratories and Watson Announce Publication of Positive Phase III PROCHIEVE® Vaginal Progesterone Gel Study Results
6. Watson to Host Conference Call and Webcast to Discuss First Quarter 2011 Earnings
7. Watson Announces Approval of Nulecit™, the First Generic Alternative to Ferrlecit® for the Treatment of Iron Deficiency Anemia
8. Watson Confirms Favorable Appeals Court Ruling on Generic SEASONIQUE® Patent Challenge
9. Watson Confirms OxyContin® Patent Challenge
10. Watson Confirms District Court Ruling in Generic Fentora® Patent Suit
11. Cephalon Wins FENTORA Patent Suit Against Watson
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/10/2014)... July 10, 2014  Valeant Pharmaceuticals International, Inc. (NYSE: ... it has completed the sale to Galderma of all ... or held by Valeant for $1.4 billion in cash, ... which recently completed its acquisition of Galderma. ... our products to a company that is firmly committed ...
(Date:7/10/2014)... BURLINGTON, Mass. , July 10, 2014 /PRNewswire/ ... three-quarters of surveyed infectious disease (ID) specialists are ... Medicines Company,s Orbactiv (oritavancin) for use as OPAT, ... to prescribe these agents to their hospital inpatients. ... percent) of OPAT patients are initiated on OPAT ...
(Date:7/10/2014)... 2014 CVS Caremark Corporation (NYSE: CVS ... a quarterly dividend of $0.275 (27.5 cents) per share on ... 1, 2014, to holders of record on July 21, 2014. ... is dedicated to helping people on their path to better ... the United States . Through the company,s more than ...
Breaking Medicine Technology:Long-Acting Antibiotics Offering Once-Weekly Dosing Will See Favorable Uptake and Use as Outpatient Parenteral Antimicrobial Therapy (OPAT) 2Long-Acting Antibiotics Offering Once-Weekly Dosing Will See Favorable Uptake and Use as Outpatient Parenteral Antimicrobial Therapy (OPAT) 3
... 17 The Department of,Justice announced today that ... CEO,Roundtable on Cancer (CRC) to develop and publicize ... cancer treatments. The Department said,the language is not ... to help,increase efficiency in contract negotiations, potentially reducing ...
... (OTC Bulletin Board: BSTC), a biopharmaceutical company,developing first ... of a U.S. Phase IIb clinical trial in ... its partner Auxlium,Pharmaceuticals, Inc., "We are very ... this trial,into a Phase IIb based on our ...
Cached Medicine Technology:Justice Department Will Not Oppose CEO Roundtable on Cancer's Proposal 2BioSpecifics Technologies Corp. Announces Initiation of Phase IIb Trial for Peyronie's Disease 2BioSpecifics Technologies Corp. Announces Initiation of Phase IIb Trial for Peyronie's Disease 3
(Date:7/11/2014)... Anterior Cruciate Ligament (ACL) happens all too frequently, however ... Orthopaedic Society for Sports Medicine,s (AOSSM) Annual Meeting suggests ... may minimize the chance of a future ACL tear. ... factors such as, age, activity level and type of ... said lead author, Christopher C. Kaeding, MD of the ...
(Date:7/11/2014)... NY (PRWEB) July 11, 2014 Wild by ... is proud to announce they are opening a fifth store ... Wild by Nature offers one of the largest selections of ... people diagnosed with celiac disease, these stores have become a ... gluten-free diet. , Gluten sensitivity, and gluten intolerance, is a ...
(Date:7/11/2014)... BellasDress, the experienced dressmaker in the ... suppliers when it comes to beach wedding dresses ... of beach wedding outfits in its online shop. Included ... outfits. , BellasDress has been considered as one ... to the company’s senior spokesman, BellasDress provides superb special ...
(Date:7/11/2014)... Growing old was thought of as a fate that was ... was shown that many of the “myths” people associate with ... out, the elderly can still live quite as fruitfully as their ... time in the world, older people also need to live a ... the twilight of their lives. This is why Guy Coalter, the ...
(Date:7/11/2014)... July 11, 2014 Plasma resource reserves ... products industry. Although the closure of 16 plasma collection ... to domestic blood products market, the total plasma volume ... on year and total lot release volume declined by ... stock consumption, insufficient utilization of new plasma stations and ...
Breaking Medicine News(10 mins):Health News:Wild by Nature Opens New Location 2Health News:BellasDress Emerges As Popular Online Supplier Of 2014 Beach Wedding Dresses 2Health News:It’s All Free For Seniors Review, How To Take Advantage of What Life Has to Offer In Old Age – Vinamy.com 2Health News:It’s All Free For Seniors Review, How To Take Advantage of What Life Has to Offer In Old Age – Vinamy.com 3Health News:Chinese Blood Product Industry Report 2014-2017 Focuses Plasma Volume & Stations Says A New Research Available at ChinaMarketResearchReports.com 2Health News:Chinese Blood Product Industry Report 2014-2017 Focuses Plasma Volume & Stations Says A New Research Available at ChinaMarketResearchReports.com 3Health News:Chinese Blood Product Industry Report 2014-2017 Focuses Plasma Volume & Stations Says A New Research Available at ChinaMarketResearchReports.com 4
... of your New Year resolutions, The Alliance for Aging Research// ... of both physical as well as mental exercise to stay ... nonprofit Alliance for Aging Research said, "There is a lot ... prevent or lessen the cognitive decline that often comes with ...
... habit of offering fruit juices and sugar added beverages ... better to avoid sugary drinks in cups with sippers ... the sipper attached. The American Academy of Pediatric Dentistry (AAPD) ... cups do help to avoid liquids from spilling over from ...
... for patients in ICU by adhering to simple techniques ... infections. // ICUs can become thoroughly aseptic by ensuring ... and catheters. A detailed report was made by experts ... the report are published in New England Journal of ...
... parents to encourage their children to put away the video ... AMA Vice President, Dr Choong-Siew Yong, said today. ... soccer balls and tennis racquets are a great way to ... ,“Swimming or horse-riding lessons, bicycle outings, backyard cricket, or just ...
... junta, left for Singapore to receive treatment for an intestinal ... who has led Myanmar's junta - the self-styled State Peace ... the country Sunday on a special flight arranged by businessman ... ,An informed source in the government said Than Shwe, ailing ...
... the calories a person consumes can prevent, or at least ... suggests// that body composition – whether a person is ... risks. ,In other words, how the body ... than how many or how few calories are consumed—a finding ...
Cached Medicine News:Health News:Simple Steps to Safe Guard Patients from Bloodstream Infections in ICU 2Health News:Keep Kids Active in the Holidays 2Health News:Body Composition Is Key Player in Controlling Cancer Risks 2
This CLS number is a new product number, created to easily match Cornings product number. If showing no availability yet, please order under the old Sigma-Aldrich number (Z71,411-9) or contact custom...
... The Eppendorf Reference Series 2000 Pipette ... smooth stroke, a compact and robust design, ... button is used to operate the measuring ... the tip. Product features: Eppendorf ...
... Seven digital models cover the range from 2ul ... fluently. Volume lock design prevents inadvertent volume ... horizontal grip. Whole pipette is autoclavable at ... is all polypropylene. Suitable for one-handed operation. ...
... a fully adjustable, air-displacement pipette with a ... latest member of the Pipetman family, sharing ... and precision. We also added a number ... customers. Eight models cover the full range ...
Medicine Products: